ArticleCanadian respiratory journal2026
Systemic Inflammatory Response Index Has a Value for the Early Diagnosis and Short-Term Prognostic Assessment of Severe Pneumonia in the Elderly.
Article in Canadian respiratory journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Prognostic value of systemic inflammatory indicators in patients with severe pneumonia.American journal of translational research · 2026Article
- Systemic Inflammatory Response Index Has a Value for the Early Diagnosis and Short-Term Prognostic Assessment of Severe Pneumonia in the Elderly.Canadian respiratory journal · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This article probed the value of systemic inflammatory response index (SIRI) in the early diagnosis and short-term prognostic assessment of severe pneumonia (SPM) in the elderly. First, 266 elderly patients with pneumonia were retrospectively included and allocated into SPM and N-SPM groups as per APACHE-II scores. Correlations of SIRI with APACHE-II scores, CRP, and PCT were analyzed. Patients were followed up for 28 days, and SPM patients were allocated into death and survival groups based on survival status. The values of SIRI for early diagnosis and short-term prognostic assessment of elderly SPM patients were evaluated. Influencing factors for short-term death in elderly SPM patients were screened. SIRI levels were high in elderly SPM patients and were positively correlated with APACHE II scores and CRP and PCT levels. SIRI had a high predictive value for the occurrence (AUC = 0.843) and 28-day survival (AUC = 0.806) of SPM. High SIRI levels elevated the risk of 28-day mortality in elderly SPM patients. APACHE II scores (HR = 1.125) and SIRI (HR = 1.977) were independent risk factors for short-term death in elderly SPM patients. Overall, SIRI has a certain value for the early diagnosis and prognostic assessment of elderly SPM patients.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.